Key facts
- It has raised $30K; the latest was Angel (individual) ($10K) in Feb 2026.
- M & A Med has filed 1 Form D with the SEC, most recently Feb 2025 ($20K sold to 301 investors).
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for M & A Med
- ·The full record, as it builds
Funding rounds
No funding rounds for M & A Med are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About M & A Med
Manufacturer of biologic and medical supplies intended for the delivery of advanced amniotic membrane tissue allografts. The company provides allografts that actively reduce inflammation, alleviate pain, and support the healing of a wide range of wounds and burns, enabling patients of all ages to access safe, accelerated healing methods.
- Sector
- Healthcare
- HQ
- Las Vegas, NV, United States
- Founded
- 2024
- Website
- mandameds.com/
- Ownership
- Privately Held (backing)
M & A Med doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in M & A Med shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on M & A Med in its N-PORT filings yet. We sweep new filings monthly.